Key Segments:
By Biomarker Type
-
Surrogate Endpoint Biomarkers
-
Predictive Biomarkers
-
Prognostic Biomarkers
-
Safety Biomarkers
By Service
-
Genomics Biomarker Services
-
Proteomics Biomarker Services
-
Bioinformatics Services
-
Other Services
By Therapeutic Area
-
Oncology
-
Cardiology
-
Neurology
-
Autoimmune Diseases
-
Other Therapeutic Areas
By End Use
-
Biotechnology Companies
-
Pharmaceutical Companies
-
Other End Use
Regional Coverage:
North America
-
US
-
Canada
Europe
-
Germany
-
France
-
UK
-
Italy
-
Spain
-
Poland
-
Russia
-
Rest of Europe
Asia Pacific
-
China
-
India
-
Japan
-
South Korea
-
Australia
-
ASEAN Countries
-
Rest of Asia Pacific
Middle East & Africa
-
UAE
-
Saudi Arabia
-
Qatar
-
South Africa
-
Rest of Middle East & Africa
Latin America
-
Brazil
-
Argentina
-
Mexico
-
Colombia
-
Rest of Latin America
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
-
Detailed Volume Analysis
-
Criss-Cross segment analysis (e.g. Product X Application)
-
Competitive Product Benchmarking
-
Geographic Analysis
-
Additional countries in any of the regions
-
Customized Data Representation
-
Detailed analysis and profiling of additional market players
Frequently Asked Questions
Key players include Almac Group, Crown Bioscience, Evotec, Frontage Laboratories, Excelra, Parexel International, Caris Life Sciences, Illumina, and 10x Genomics, among others.
Key opportunities include expanding companion diagnostic co-development, rising predictive biomarker demand, and growing capacity investment across emerging research hubs in Asia Pacific.
The market is driven by rising precision medicine adoption, growing sponsor preference for outsourced multi-omic biomarker discovery, and expanding companion diagnostic co-development requirements.
The Genomics Biomarker Services segment dominated the Biomarker Discovery Outsourcing Services Market, accounting for approximately 35.60% share in 2025.
The North America region dominated the Biomarker Discovery Outsourcing Services Market in 2025 with approximately 47.20% revenue share.